Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma
Abstract Background Lung cancer is the most common cancer and cause of cancer‐related mortality worldwide, increasing evidence indicated that there was a significant correlation between tumors and the long non‐coding RNAs (lncRNAs), as well as tumor immune infiltration, but their role in early lung...
Prif Awduron: | Lan Mu, Ke Ding, Ranran Tu, Wei Yang |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
BMC
2021-03-01
|
Cyfres: | Journal of Translational Medicine |
Pynciau: | |
Mynediad Ar-lein: | https://doi.org/10.1186/s12967-021-02800-x |
Eitemau Tebyg
-
A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
gan: Chengyu Bian, et al.
Cyhoeddwyd: (2022-08-01) -
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
gan: Guomin Wu, et al.
Cyhoeddwyd: (2021-07-01) -
Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
gan: Hua Huang, et al.
Cyhoeddwyd: (2022-03-01) -
Construction of an immunogenic cell death-related LncRNA signature to predict the prognosis of patients with lung adenocarcinoma
gan: Shuaishuai Wang, et al.
Cyhoeddwyd: (2024-11-01) -
Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
gan: Pengpeng Zhang, et al.
Cyhoeddwyd: (2023-01-01)